Gesundheit
Perrigo recalls 16,500 jars of baby formula
Perrigo has initiated a voluntary recall of three lots within one batch, or 16,500 cans, of its infant formula sold at HEB Grocery Company and
US FDA approves Citius therapy to treat rare blood cancer
The U.S. Food and Drug Administration has approved a drug Citius Pharmaceuticals company said Thursday is a therapy for patients with a form of blood
U.S. FDA extends review of Humacyte blood vessel implant
Humacyte U.S. health regulator said it has expanded the company’s authority to test an implant that can replace a damaged or injured blood vessel, causing
US FDA refuses to approve first MDMA-based treatment for PTSD
The U.S. FDA has refused to approve a mind-altering MDMA-based therapy for patients with post-traumatic stress disorder, saying it cannot be approved based on the
US FDA approves Novartis drug to treat kidney disease
The US Food and Drug Administration has approved the use of a Novartis drug to reduce excess protein in the urine of patients with a
Servier’s brain tumour treatment approved by US FDA
Servier Pharmaceuticals said the US FDA approved its treatment for a type of brain tumour, becoming the first drug to gain approval in the US
CVS Health cuts its 2024 profit forecast again
CVS Health cut its 2024 profit forecast due to persistently high medical costs in its business offering government-backed insurance plans, sending its shares down 4%
Novo Nordisk shares fall
Novo Nordisk cut its full-year earnings outlook after reporting weaker-than-expected quarterly sales of its popular weight-loss drug Wegovy, raising concerns among investors about growing competition
Neuralink implanted a brain chip in a second test patient
Neuralink has successfully implanted a second patient with its device designed to give paralyzed patients the ability to use digital devices simply by thinking, according
BioNTech hopes to move into cancer drugs
Losses at German pharmaceutical company BioNTech quadrupled in the second quarter compared to the previous year. Now the company is confident in a change of